DexCom Inc (DXCM) — Quality & forensics

As of 2026-08-06 — refreshed nightly. Closelook readings from an investment research diary, not ratings or advice.

The Closelook module scores

66 /100 composite · 7 modules · general weight set

Valuation 56
Quality 78
Growth 66
Balance sheet 64
Cash quality 57
Capital allocation 63
Momentum 70

Scores are computed nightly across the coverage universe and read relative to it — the methodology lives in the company-scoring explainer.

Financial forensics — the academic screens

7.36 Altman Z-Score

Sits in the safe zone (above 2.99). The Z-Score estimates financial-distress risk from five balance-sheet and earnings ratios.

7/9 Piotroski F-Score

Nine binary fundamental-strength checks across profitability, leverage and operating efficiency.

-2.66 Beneish M-Score

Screens reported earnings for statistical manipulation patterns — below the −1.78 manipulation-risk threshold. A screen, not an accusation.

Continue: the DXCM chart & overview

FAQ · from the current data · as of 2026-08-06

Quick answers

What is DexCom Inc's Closelook quality reading?

The composite reads 66/100 across 7 modules, as of 2026-08-06: valuation 56, quality 78, growth 66, balance sheet 64, cash quality 57, capital allocation 63, momentum 70. Closelook scores are research diary readings, not ratings or investment advice.

What is DexCom Inc's Altman Z-Score?

7.36, which sits in the safe zone (above 2.99) as of 2026-08-06. The Altman Z-Score estimates financial distress risk from five balance-sheet and earnings ratios.

What is DexCom Inc's Piotroski F-Score?

7 of 9, as of 2026-08-06. The F-Score counts nine binary fundamental-strength signals across profitability, leverage and operating efficiency.

What does DexCom Inc's Beneish M-Score indicate?

-2.66 — below the −1.78 manipulation-risk threshold, as of 2026-08-06. The M-Score screens reported earnings for statistical manipulation patterns; it is a screen, not an accusation.